
|Videos|November 24, 2015
Q&A With David Reich From Hahnemann University Hospital: ELAD System Shows Promise For Artificial Liver Function
Author(s)Adam Hochron
In the past patients with alcoholic liver disease may not have been considered viable options for liver transplants. A recent study looked at whether an artificial device could help these patients return to a normal quality of life.
Advertisement
In the past patients with alcoholic liver disease may not have been considered viable options for liver transplants. A recent study looked at whether an artificial device could help these patients return to a normal quality of life.
David J. Reich, MD, from Hahnemann University Hospital discussed the results of the study which were presented at the annual Liver Meeting in San Francisco.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on HCPLive
1
TRIUMPH-1: Retatrutide Substantially Lowers Weight, BMI in Patients With Obesity or Overweight
2
TRANSCEND-T2D-1: Retatrutide Demonstrates Superior Weight Loss and A1c Results Versus Placebo
3
High-Dose Semaglutide Preserves Kidney Function, Reduces Inflammation in Obesity Without Diabetes
4
Berobenatide Monthly Dosing Shows Weight Loss Efficacy in VESPER Trials, With John Buse, MD, PhD
5


























































